You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 143 No. 2, February 1983 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  TODAY'S PRACTICE OF MEDICINE
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (25)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Gastric Ulcer

What Is Old and What Is New

James H. Lewis, MD

Arch Intern Med. 1983;143(2):264-274.


Abstract



• The rational treatment of gastric ulcer (GU) requires both an understanding of the various causative factors responsible for what is best considered a spectrum of disorders, as well as a familiarity with the newer antisecretory and cytoprotective therapies that are available. Gastric ulcers that fulfill the criteria to be peptic ulcers (ie, occur in the antrum in the presence of excess luminal acid, with or without a coexisting duodenal ulcer) are best treated with a histamine H2-receptor antagonist. For GUs that develop in the setting of normal or reduced acid output, or those that occur as a result of direct (ie, drug-induced or bile acid-related) mucosal injury, use of a cytoprotective agent (eg, sucralfate) is the treatment of choice. Any GU that falls to heal within 12 to 15 weeks should be carefully examined to exclude the presence of a malignant neoplasm and should be considered for surgical resection.

(Arch Intern Med 1983;143:264-274)



Author Affiliations



From the Department of Medicine, Division of Gastroenterology, George Washington School of Medicine and Health Sciences, Washington, DC.


Footnotes



Accepted for publication Sept 20, 1982.

Reprint requests to the Department of Medicine, Division of Gastroenterology, George Washington School of Medicine and Health Sciences, 2150 Pennsylvania Ave NW, Washington, DC 20037 (Dr Lewis).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Benign Gastric Ulcer and Cimetidine: Questions About Study Design
SACHERE
ANN INTERN MED 1985;103:636-637.
ABSTRACT  

Healing of Benign Gastric Ulcer: Comparison of Cimetidine and Placebo in the United States
GRAHAM et al.
ANN INTERN MED 1985;102:573-576.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.